Sotera Health (NASDAQ:SHC) Stock Holdings Lifted by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC lifted its position in Sotera Health (NASDAQ:SHC) by 15.9% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 82,654 shares of the company’s stock after acquiring an additional 11,342 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Sotera Health were worth $1,380,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in SHC. CWM LLC lifted its position in shares of Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after purchasing an additional 993 shares in the last quarter. GAMMA Investing LLC lifted its position in Sotera Health by 125.0% in the 3rd quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock worth $50,000 after buying an additional 1,660 shares in the last quarter. Point72 DIFC Ltd boosted its stake in shares of Sotera Health by 556.6% during the 2nd quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock valued at $78,000 after buying an additional 5,544 shares during the period. Capital Performance Advisors LLP purchased a new position in shares of Sotera Health during the 3rd quarter valued at $91,000. Finally, Acadian Asset Management LLC increased its stake in shares of Sotera Health by 728.0% in the second quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock worth $111,000 after acquiring an additional 8,248 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Insider Transactions at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the sale, the director now owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. This trade represents a 16.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 55.12% of the company’s stock.

Sotera Health Price Performance

Shares of SHC opened at $13.30 on Tuesday. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The stock has a market cap of $3.77 billion, a P/E ratio of 53.20 and a beta of 2.08. The stock’s 50-day moving average price is $15.54 and its two-hundred day moving average price is $13.99.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm had revenue of $285.47 million for the quarter, compared to analyst estimates of $278.64 million. During the same quarter in the previous year, the firm posted $0.18 earnings per share. Sotera Health’s quarterly revenue was up 8.5% on a year-over-year basis. On average, equities analysts predict that Sotera Health will post 0.61 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on SHC. Royal Bank of Canada reissued an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research report on Thursday, November 21st. Barclays boosted their price target on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research note on Tuesday, August 6th. Finally, Citigroup raised their price objective on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Sotera Health has an average rating of “Moderate Buy” and an average price target of $16.50.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.